tirzepatide gout Zepbound Injection 5 mg/0.5 mL — Mountainside Medical Tirzepatide as a Potential Disease-Modifying

E.InoueS.SasakiM.GorriniC.LeeK

10.1172/JCI119868 35

Two dosing approaches: The schedule below is the FDA-approved clinical trial protocol from the STEP trials

Helicobacter pylori infection in Hispanics: comparison with Blacks and Whites of similar age and socioeconomic class

Key approved indications include: Type 2 diabetes mellitus management (Mounjaro) Chronic weight management in obesity or overweight with comorbidities (Zepbound) Use as adjunct to lifestyle modification (diet and exercise) It is critical to recognize that tirzepatide has no FDA approval for the treatment, prevention, or management of autoimmune diseases